Q3 2025 Koninklijke Philips NV Earnings Call Transcript
Key Points
- Order intake grew by 8%, marking the fourth consecutive quarter of improvement, driven by strong demand in North America.
- Comparable sales growth increased by 3% year on year, with all business segments contributing to growth.
- Adjusted EBITA margin expanded by 50 basis points to 12.3%, reflecting solid gross margin delivery and effective cost management.
- Personal Health segment saw an 11% increase in sales, with strong performance across all regions and product lines.
- The company achieved EUR222 million in productivity savings in Q3, bringing the year-to-date total to EUR566 million, on track to meet the full-year target of EUR800 million.
- The FDA issued a warning letter, which, although not expected to impact operations, highlights ongoing regulatory challenges.
- Tariffs continue to pose a financial burden, with an expected net impact of EUR150 million to EUR200 million for the full year.
- Diagnostic Imaging sales experienced a modest decline due to the timing of orders, impacting overall growth in the Diagnosis and Treatment segment.
- China's market remains subdued, with slower order conversion and increased competition affecting growth prospects.
- Enterprise Informatics sales have been flat, with a long order conversion cycle delaying revenue realization.
Welcome to the Royal Philips' third-quarter 2025 results conference call on Tuesday, November 4, 2025. During the call hosted by Mr. Roy Jakobs, CEO; and Ms. Charlotte Hanneman, CFO, all participants will be in a listen-only mode. (Operator Instructions)
Please note that this call will be recorded, and a replay will be available on the Investor Relations website of Royal Philips. I will now hand the conference over to Mr. Durga Doraisamy, Head of Investor Relations. Please go ahead, madam.
Hello, everyone. Welcome to Philips' results webcast for the third quarter of 2025. I'm here with our CEO, Roy Jakobs; and our CFO, Charlotte Hanneman.
The press release and the investor presentation can be accessed on our Investor Relations website. The replay and full transcript of this webcast will be available on our website after this call concludes. I want to draw your attention to our Safe Harbor statement on the screen and in the presentation.
I will now hand over to Roy.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
